RECOVERY Trial: Tocilizumab in Hospitalised COVID-19 Patients
- ICU
- 16/02/2021
A large majority of COVID-19 infections are mild or asymptomatic. However, there is a significant portion of individuals who develop severe respiratory illness that requires hospital care, and that...
READ MORE